- Hlavní
- Analytika
- Zprávy z trhu
- Company news: Merck (MRK) quarterly results beat analysts’ estimates
Ekonomické zprávy
31.10.2024
Company news: Merck (MRK) quarterly results beat analysts’ estimates
Merck (MRK) reported Q3 FY2024 earnings of $1.57 per share (versus $2.13 per share in Q3 FY2023), beating analysts’ consensus estimate of $1.48 per share.
The company’s quarterly revenues amounted to $16.657 bln (+4.4% y/y), beating analysts’ consensus estimate of $16.474 bln.
The company also lowered FY2024 EPS guidance to $7.72-7.77 from its previous guidance of $7.94-8.04 versus analysts’ consensus estimate of $7.75 and narrowed its FY2024 revenue guidance to $63.6-64.1 bln from its previous guidance of $63.4-64.4 bln versus analysts’ consensus estimate of $64.14 bln.
MRK fell to $102.60 (-2.13%) in pre-market trading.
Podívejte se také